These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G; Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506 [TBL] [Abstract][Full Text] [Related]
6. Pathogen-reduced platelets for the prevention of bleeding. Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569 [TBL] [Abstract][Full Text] [Related]
7. Neonatal Platelet Transfusions and Future Areas of Research. Sola-Visner M; Bercovitz RS Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660 [TBL] [Abstract][Full Text] [Related]
8. The practice of platelet transfusion prior to central venous catheterization in presence of coagulopathy: a national survey among clinicians. van de Weerdt EK; Peters AL; Goudswaard EJ; Binnekade JM; van Lienden KP; Biemond BJ; Vlaar APJ Vox Sang; 2017 May; 112(4):343-351. PubMed ID: 28261815 [TBL] [Abstract][Full Text] [Related]
9. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Stanworth SJ; Hyde C; Brunskill S; Murphy MF Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634 [TBL] [Abstract][Full Text] [Related]
10. [Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM]. Dettori I; Ladaique P Transfus Clin Biol; 2014 Nov; 21(4-5):207-9. PubMed ID: 25267204 [TBL] [Abstract][Full Text] [Related]
11. Acute profound thrombocytopenia following abciximab therapy. Bishara AI; Hagmeyer KO Ann Pharmacother; 2000; 34(7-8):924-30. PubMed ID: 10928405 [TBL] [Abstract][Full Text] [Related]
12. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia. Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840 [TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323 [TBL] [Abstract][Full Text] [Related]
14. Compliance with prophylactic platelet transfusion trigger in haematological patients. Eikenboom JC; van Wordragen R; Brand A Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128 [TBL] [Abstract][Full Text] [Related]
15. Platelet transfusions for patients with haematological malignancies: who needs them? Estcourt LJ; Stanworth SJ; Murphy MF Br J Haematol; 2011 Aug; 154(4):425-40. PubMed ID: 21615375 [TBL] [Abstract][Full Text] [Related]
16. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES. Gubanova MN; Ayupova RF; Zhiburt EB Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588 [TBL] [Abstract][Full Text] [Related]
17. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study. Estcourt LJ; Stanworth SJ; Harrison P; Powter G; McClure M; Murphy MF; Mumford AD Br J Haematol; 2014 Aug; 166(4):581-91. PubMed ID: 24797282 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979 [TBL] [Abstract][Full Text] [Related]
19. Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology. Barillà F; Pelliccia F; Borzi M; Camici P; Cas LD; Di Biase M; Indolfi C; Mercuro G; Montemurro V; Padeletti L; Filardi PP; Vizza CD; Romeo F; J Cardiovasc Med (Hagerstown); 2017 Jan; 18(1):1-9. PubMed ID: 27635937 [TBL] [Abstract][Full Text] [Related]
20. Haematological cancer: Prophylactic platelet transfusion is frequently not necessary. Schiffer CA Nat Rev Clin Oncol; 2013 Aug; 10(8):431-2. PubMed ID: 23820637 [No Abstract] [Full Text] [Related] [Next] [New Search]